Patients who reach the hospital in time can still miss heart attack treatment because of cost, Dr Justin Paul told the National CVD Summit. He wants tenecteplase brought under price control.
If you believe no one should miss heart attack treatment because of what it costs, follow for more from NCVD 2026.
#NCVD2026 #STEMI #Thrombolysis
@drcharit@zainultricog@prateek_golecha
"The elephant in the room is the cardiovascular disease burden in our country.” Dr S.S. Iyengar of Manipal Hospital on taking heart care guidelines to the grassroots.
#NCVD2026@drcharit@zainultricog@prateek_golecha
Heart attack patients at Sub-District Hospital Ponda once waited one to two hours for treatment while being moved to Goa Medical College.
Now the ECG report is back in a minute or two, and treatment starts on site.
Dr Amitash Balekar explains how in Summit Voices.
#STEMI#ECG #Tricog
Day two of the National CVD Summit 2026 closed with dinner in Varca, Goa, bringing together cardiologists, state health delegates, and the Tricog team. Thank you to the Government of Goa for organising the summit with us.
@drcharit@zainultricog@prateek_golecha#NCVD2026
Dr Sharad Chandra on the diagnostic gap in women's heart failure: smaller hearts mean "normal" echo readings can mask real disease, and lower BNP levels after menopause mean biomarker thresholds miss it too.
The result: women get less than a third of trial representation, yet often need only half the drug dose men do to see benefit.
#NationalCVDSummit #WomensHeartHealth @tricoghealth
@drcharit's data mining findings: across 1.3 million ECGs from 700 hospitals in Maharashtra, 1 in 21 showed signs of heart failure, most of them not classic heart attack presentations.
The sharpest finding: prevalence was highest in Nandurbar, a tribal belt, where access to care is hardest to reach.
#NationalCVDSummit #HeartFailure @tricoghealth
Dr Maitreyee Bhattacharyya on Assam's hidden heart failure burden: rheumatic heart disease in tea garden communities, rising ischemic disease in cities, and river-island areas cut off by seasonal flooding.
Her answer: a four-tier care pathway, from ASHA workers doing symptom checks to tertiary cath labs, tracked through a new state registry.
#NationalCVDSummit #HeartFailure @tricoghealth
Dr S. Harikrishnan's National Heart Failure Registry: 10,940 patients, mean age 59.9, a full decade younger than Western and Chinese registries.
Only 47% received full guideline-directed therapy. Device therapy, such as ICDs and CRT, was under 2% in India, compared with 13- 14% in Europe.
#NationalCVDSummit #HeartFailure @tricoghealth
Dr P.B. Jayagopal's warning: heart failure mortality in India, near 21% at one year, is now worse than several common cancers.
A striking gap: in a survey of over 2,000 healthcare professionals, 99% rated their understanding as good. Only 9% actually got the therapy right.
#NationalCVDSummit #HeartFailure @tricoghealth
Before any AI tool enters a cardiology workflow, Dr Muthu Dhandapani, VP Quality & Regulatory Affairs, says six questions come first.
Top of the list: Is it validated on Indian patients, and is a clinician still in the loop?
#NationalCVDSummit#CardiacCare@tricoghealth
Every ECG @tricoghealth report carries a 10-minute promise, says Dr Sudha Rammohan, VP Medical Operations.
Her team's principle: accuracy doesn't fail loudly; it slips quietly, so every doctor is tested monthly, not just trained once.
#NationalCVDSummit#CardiacCare
Dr @zainultricog, Co-founder of @tricoghealth: In India, a heart attack response beyond six hours cuts survival odds below 20%.
His team's AI and hardware stack exists to flip that number, cutting doctor review time from 3 minutes to under 30 seconds per ECG.
#NationalCVDSummit #CardiacCare
Dr Y. Premchandra Singh, Director of Health Services, Manipur: a state facing three years of conflict, rare terrain and only one PCI-enabled medical college out of four.
Eight months into a digital ECG network, it has already identified 50+ STEMI cases and 15 previously undetected heart conditions.
#NationalCVDSummit #CardiacCare @tricoghealth
Dr Beena Joshi laid out India's Health Technology Assessment process, still young, but already with a track record: a sickle cell diagnostic taken from ₹3 lakh to under ₹100, and newborn heart screening shown to be cost-effective at scale.
Her standard for any innovation: does it work, and is it worth what it costs?
#NationalCVDSummit #HealthPolicy @tricoghealth
In the news: RDX Goa covers today's inauguration of the National CVD Summit 2026 by Health Minister Vishwajit Rane, spotlighting Goa's STEMI programme, 20 spokes strong, and its impact on early mortality.
#NationalCVDSummit#NCVD2026@rdxgoa@tricoghealth
Dr Saroj Kumar Sahoo's ICMR-backed project found near-zero thrombolysis rates across parts of rural Odisha before a triage and training overhaul.
The fix: red/yellow tagging, ECG training for nurses, and WhatsApp-based teleconsultation, taking patients from zero treatment to their district's first successful thrombolysis.
#NationalCVDSummit #STEMICare @tricoghealth